A novel heterozygous NR1H4 termination codon mutation in idiopathic infantile cholestasis
- 1 June 2011
- journal article
- research article
- Published by Springer Nature in World Journal of Pediatrics
- Vol. 8 (1), 67-71
- https://doi.org/10.1007/s12519-011-0299-z
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- FXR: a metabolic regulator and cell protectorCell Research, 2008
- Farnesoid X receptor antagonizes nuclear factor κB in hepatic inflammatory responseHepatology, 2008
- Variation of the gene encoding the nuclear bile salt receptor FXR and gallstone susceptibility in mice and humansJournal of Hepatology, 2008
- Role of Farnesoid X Receptor in the Enhancement of Canalicular Bile Acid Output and Excretion of Unconjugated Bile Acids: A Mechanism for Protection against Cholic Acid-Induced Liver ToxicityJournal of Pharmacology and Experimental Therapeutics, 2004
- Molecular Basis for Feedback Regulation of Bile Acid Synthesis by Nuclear ReceptorsMolecular Cell, 2000
- A Regulatory Cascade of the Nuclear Receptors FXR, SHP-1, and LRH-1 Represses Bile Acid BiosynthesisMolecular Cell, 2000
- Bile acids are physiological ligands for a nuclear receptorGut, 2000
- Endogenous Bile Acids Are Ligands for the Nuclear Receptor FXR/BARMolecular Cell, 1999
- Progressive familial intrahepatic cholestasis types 1, 2, and 3Gut, 1998
- Progressive familial intrahepatic cholestasis (PFIC): evidence for genetic heterogeneity by exclusion of linkage to chromosome 18q21-q22Human Genetics, 1997